PIP-ENALAPRIL enalapril maleate 5mg tablet blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

enalapril maleate, Quantity: 5 mg

Mevcut itibaren:

GM Pharma International Pty Ltd

INN (International Adı):

enalapril maleate

Farmasötik formu:

Tablet

Kompozisyon:

Excipient Ingredients: lactose monohydrate; hypromellose; maleic acid; croscarmellose sodium; sodium stearylfumarate

Uygulama yolu:

Oral

Paketteki üniteler:

30

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

HYPERTENSION ,Enalapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. ,CONGESTIVE HEART FAILURE ,Enalapril is indicated for the treatment of all degrees of symptomatic heart failure. In such patients, it is recommended that Enalapril be administered together with a diuretic. ,LEFT VENTRICULAR DYSFUNCTION ,All degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35 percent, irrespective of the presence or severity of obvious symptoms of heart failure.

Ürün özeti:

Visual Identification: White to off white, round, flat faced, beveled edge tablets with breakline on one side and "5" debossed on the other side.; Container Type: Carton; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2013-05-28